Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus, Type 2 × Resistance Training × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 2 Endocrine 1

Conditions

Pituitary Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Motor Activity 1 Limb-girdle muscular dystrophy, type 2C 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1

Interventions

relacorilant 4 somapacitan 1 pembrolizumab 1 Resistance Training 1 Exercise 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00786019 2023-07-12

InsITE

University of Colorado, Denver

Phase NA Completed

47 enrolled 22 charts

Limb-girdle muscular dystrophy, type 2C, Diabetes Mellitus, Diabetes Mellitus, Type 2, Motor Activity, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡